Incannex has no plans, requirement to fully utilized ATM in near term

Incannex (IXHL) Healthcare announced, in response to recent questions it received from a number of its stockholders, that it does not presently intend to use the full capacity available under its at the market offering program, the ATM, in the near-term. As previously disclosed in the Company’s Form 8-K filed with the U.S. Securities and Exchange Commission on July 24, 2025, the Company is under no obligation to issue any shares of its common stock pursuant to the ATM and any utilisation of the ATM will be at the discretion of the Company, taking into account prevailing market conditions and strategic priorities. The Company’s general practice is to make use of the ATM in its discretion, but in limited amounts compared to the then-present daily trading volume. With a strong current cash balance of approximately US$50 million, Incannex is well positioned to advance its portfolio of drug candidates through the next stages of development.